TD Asset Management
IART icon

TD Asset Management’s Integra LifeSciences IART Stock Holding History

TD Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8,200
Closed -$338K – 1384
2016
Q3 		$338K Buy
+8,200
New +$344K ﹤0.01% 1276

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

TD Asset Management's IART Position: Q4 2016 in Review

TD Asset Management sold out of Integra LifeSciences (IART) in Q4 2016, closing a stake of 8,200 shares — an estimated $338K sold.

TD Asset Management first reported a position in IART in Q3 2016 and held it in 1 quarter. The position peaked at $338K in Q3 2016. 223 funds tracked by Wall St. Rank hold IART as of Q4 2016.

  • TD Asset Management reported no remaining Integra LifeSciences position as of Q4 2016 after selling out during the quarter.
  • TD Asset Management sold 8,200 Integra LifeSciences shares in Q4 2016, an estimated $338K.
  • TD Asset Management first reported a position in Integra LifeSciences in Q3 2016 and held it in 1 quarter.
  • TD Asset Management's Integra LifeSciences position peaked at $338K in Q3 2016.
  • 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.

Based on TD Asset Management's 13F filing for Q4 2016, filed 8 Feb 2017.